BOUNDLESS: AN ACTIVE-CONTROLLED, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY TRIAL OF CONTINUOUS SUBCUTANEOUS INFUSION OF LEVODOPA/CARBIDOPA WITH ND0612 IN PATIENTS WITH PARKINSON'S DISEASE

被引：0
|
作者：
Rascol, O. [1 ,2 ]
Poewe, W. [3 ]
Stocchi, F. [4 ]
Yardeni, T. [5 ]
Barak, S. Leibman [5 ]
Adar, L. [5 ]
Rosenfeld, O. [5 ]
Olanow, C. W. [6 ]
机构：
[1] Univ Toulouse, CHU Toulouse, Toulouse, France
[2] INSERM, Toulouse, France
[3] Med Univ Innsbruck, Innsbruck, Austria
[4] IRCCS San Raffaele Pisana, Inst Neurol, Rome, Italy
[5] NeuroDerm Ltd, Rehovot, Israel
[6] Clintrex, Sarasota, FL USA
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 186
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [1] BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease experiencing motor complications
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Yardeni, T.
    Adar, L.
    Rosenfeld, O.
    Olanow, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1105 - 1105
  • [2] BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson's disease
    Poewe, W.
    Kieburtz, K.
    Stocchi, F.
    Oren, S.
    Yardeni, T.
    Adar, L.
    Rosenfeld, O.
    Olanow, C.
    MOVEMENT DISORDERS, 2019, 34 : S74 - S74
  • [3] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
    Espay, Alberto J.
    Stocchi, Fabrizio
    Pahwa, Rajesh
    Albanese, Alberto
    Ellenbogen, Aaron
    Ferreira, Joaquim J.
    Giladi, Nir
    Gurevich, Tanya
    Hassin-Baer, Sharon
    Hernandez-Vara, Jorge
    Isaacson, Stuart H.
    Kieburtz, Karl
    Lewitt, Peter A.
    Lopez-Manzanares, Lydia
    Olanow, C. Warren
    Poewe, Werner
    Sarva, Harini
    Yardeni, Tami
    Adar, Liat
    Salin, Laurence
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (05): : 465 - 476
  • [4] BouNDless: Study Design of an Active-Controlled, Randomized, Double-Blind Double-Dummy Study of Continuous ND0612 Infusion in Patients with Parkinson's Disease and Motor Fluctuations
    Espay, A.
    Kieburtz, K.
    Olanow, C. W.
    Case, R.
    Yardeni, T.
    Sasson, N.
    Adar, L.
    Rascol, O.
    MOVEMENT DISORDERS, 2022, 37 : S8 - S8
  • [5] The BouNDless Study: An Active-Controlled, Randomized, Double-Blind, Double-Dummy Phase 3 Study of Continuous ND0612 Infusion in Patients with Parkinson's Disease Experiencing Motor Fluctuations
    Espay, Alberto
    Rascol, Olivier
    Yardeni, Tamar
    Adar, Liat
    Rosenfeld, Olivia
    Case, Ryan
    Olanow, C. Warren
    NEUROLOGY, 2020, 94 (15)
  • [6] CONTINUOUS SUBCUTANEOUS LEVODOPA/CARBIDOPA INFUSION (ND0612) FOR PATIENTS WITH PARKINSON'S DISEASE AND MOTOR FLUCTUATIONS: A PHASE 3, ACTIVE-CONTROLLED STUDY (BOUNDLESS)
    Stocchi, F.
    Espay, A.
    Albanese, A.
    Ellenbogen, A.
    Ferreira, J. J.
    Giladi, N.
    Gurevich, T.
    Hassin-Baer, S.
    Hernandez-Vara, J.
    Isaacson, S.
    Kieburtz, K.
    LeWitt, P.
    Lopez-Manzanares, L.
    Olanow, C. W.
    Pahwa, R.
    Poewe, W.
    Sarva, H.
    Yardeni, T.
    Adar, L.
    Lopes, N.
    Sasson, N.
    Case, R.
    Rascol, O.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [7] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial (vol 43, pg 465, 2024)
    Espay, A. J.
    Stocchi, F.
    Pahwa, R.
    LANCET NEUROLOGY, 2024, 23 (06): : E10 - E10
  • [8] Continuous Subcutaneous Levodopa/Carbidopa Infusion With ND0612 For Patients With Parkinson's Disease And Motor Fluctuations: Results From The Phase 3 Randomized, Active-Controlled BouNDless Study
    Rascol, O.
    Albanese, A.
    Ellenbogen, A.
    Ferreira, J.
    Giladi, N.
    Gurevich, T.
    Hassin-Baer, S.
    Hernandez-Vara, J.
    Isaacson, S.
    Kieburtz, K.
    LeWitt, P.
    Lopez-Manzanares, L.
    Olanow, C. W.
    Pahwa, R.
    Poewe, W.
    Sarva, H.
    Stocchi, F.
    Yardeni, T.
    Adar, L.
    Salin, L.
    Lopes, N.
    Sasson, N.
    Case, R.
    Espay, A.
    MOVEMENT DISORDERS, 2023, 38 : S4 - S4
  • [9] Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
    Olanow, C. Warren
    Kieburtz, Karl
    Odin, Per
    Espay, Alberto J.
    Standaert, David G.
    Fernandez, Hubert H.
    Vanagunas, Arvydas
    Othman, Ahmed A.
    Widnell, Katherine L.
    Robieson, Weining Z.
    Pritchett, Yili
    Chatamra, Krai
    Benesh, Janet
    Lenz, Robert A.
    Antonini, Angelo
    LANCET NEUROLOGY, 2014, 13 (02): : 141 - 149
  • [10] ND0612 infusion in fluctuating Parkinson's disease: a randomised, double-blind, placebo-controlled study
    Stocchi, F.
    Lewitt, P.
    Isaacson, S.
    Leionen, M.
    Minei, T. Rachmilewitz
    Oren, S.
    Kieburtz, K.
    Olanow, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 515 - 515
12345